Australia's Icon Group adopts IBM Watson for Oncology ZDNet

Queensland-based Icon Group has announced plans to adopt IBM Watson for Oncology, an artificial intelligence (AI) and cognitive computing platform that will provide the organisation's oncologists with access to massive amounts of global research to help them better inform patient treatment plans. "Being in the cancer care sector, we've been watching with great interest the way that Watson for Oncology has been utilised in other markets," Cathie Reid, co-founder of Icon Group, told ZDNet. "There's an incredible amount of medical literature already available and that's growing at an exponential rate and being able to have that information available in a curated form at the touch of your fingertips is something that our physicians are very excited about.